ISSN: 0030-2414

Journal Home

Journal Guideline

Oncology Q2 Unclaimed

S. Karger AG Switzerland

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Oncology is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 107. It has an SJR impact factor of 0,832 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,832.

Oncology focuses its scope in these topics and keywords: cancer, patients, breast, prevalence, phosphatase, oxaliplatin, overexpression, ovarian, oncoprotein, metastasis, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q2) Medicine (miscellaneous) (Q2) Oncology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,832

SJR Impact factor

107

H Index

85

Total Docs (Last Year)

276

Total Docs (3 years)

2687

Total Refs

771

Total Cites (3 years)

270

Citable Docs (3 years)

2.5

Cites/Doc (2 years)

31.61

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

Decision Making Criteria in Oncology

Molecular Targets in Cancer Therapy and Their Impact on Cancer Management

Loss of p16/CDKN2A Protein in Epstein-Barr Virus-Associated Gastric Carcinoma

Loss of p27 Expression Is Associated with Poor Prognosis in Stage I-II Pancreatic Cancer

Hyperimmunoglobulinemia D following Cancer Chemotherapy

Skp2 and Jab1 Expression Are Associated with Inverse Expression of p27KIP1 and Poor Prognosis in Oral Squamous Cell Carcinomas

Hemolytic-Uremic Syndrome during Therapy with Estramustine Phosphate for Advanced Prostatic Cancer

Pharmacology of Ifosfamide

Changes in Apoptosis and Mitotic Index, p53 and Ki67 Expression in Various Types of Oral Leukoplakia

Flow Cytometry and Squamous Cell Carcinoma of the Maxillary Sinus: A Possible Prognostic Indicator for Multimodality Intervention

High Impact of Histopathological Remission for Prognosis after Perioperative Chemotherapy with ECF and ECF-Like Regimens for Gastric and Gastroesophageal Adenocarcinoma

Frequent Amplification of C-erbB2 (HER-2/Neu) Oncogene in Cervical Carcinoma as Detected by Non-Fluorescence in situ Hybridization Technique on Paraffin Sections

SHOW MORE ARTICLES

nm23 in the Primary and Metastatic Sites of Gastric Carcinoma

Rivizor -A New Third-Generation Aromatase Inhibitor for the Treatment of Advanced Breast Cancer after Tamoxifen Failure

Cyclin D3 Expression, Cell Proliferation and Pathological Stage of Human Primary Colorectal Cancer

Gross Pathologic Types of Hepatocellular Carcinoma in Italy

Inhibition of Tumor Metastasis by Sodium Caffeate and Its Effect on Angiogenesis

Safety and Efficacy of Modified FOLFIRINOX for Advanced Pancreatic Adenocarcinoma: A UK Single-Centre Experience

Comparison of Low-Dose versus Standard-Dose Colony Stimulating Factor in Patients with Chemotherapy-Induced Febrile Neutropenia

Clinicopathological Significance of Stromelysin-3 Expression in Colorectal Cancer

Local Control after Curative Surgery for Cancer of the Extraperitoneal Rectum

Impact of Interval Debulking Surgery on Clinical Outcome in Primary Unresectable FIGO Stage IIIc Ovarian Cancer Patients

Beta-Catenin Expression in Intramucosal Neoplastic Lesions of the Stomach

Chronological Changes in Incidences of Polymorphic Reticulosis in Korea and Japan